Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

676
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
676
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Drug Therapy01:28

Drug Therapy

414
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
414
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

916
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
916
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.4K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of centrally acting sympatholytic agents on the blood pressure response to renal denervation.

Journal of hypertension·2025
Same author

2025 Update on resistant hypertension in CKD: where do we stand and where do we go?

Clinical kidney journal·2025
Same author

Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure.

European journal of heart failure·2025
Same author

Effect of renal denervation on the lipid profile in patients with or without coronary artery disease.

Clinical research in cardiology : official journal of the German Cardiac Society·2025
Same author

Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease.

Hypertension (Dallas, Tex. : 1979)·2025
Same author

Effects of Combination Treatment on Renal Endothelial Function in Type 2 Diabetes Mellitus.

Kidney international reports·2025
Same journal

Cost-Effectiveness and Budget Impact Analysis of Radiofrequency Renal Denervation for Uncontrolled and Resistant Hypertension in Italy.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same journal

Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same journal

Reciprocal Relationship Between Cardiovascular Risk and Attainment of Blood Pressure and Cholesterol Targets in Users of a Mobile Health App.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same journal

Phenotype-Guided Renal Denervation: the Key to Therapeutic Response.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same journal

Atherogenic Index of Plasma as Predictor for Cardiovascular Events and Cardiometabolic Diseases:Findings from the PAMELA Study.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same journal

Sex Differences in the Usefulness of Unattended Blood Pressure Measurement in Patients with Arterial Hypertension.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
See all related articles

Related Experiment Video

Updated: Apr 11, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K

Managing Treatment-Resistant Patients.

Roland E Schmieder1

  • 1Department of Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen, Germany, Roland.Schmieder@uk-erlangen.de.

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|May 31, 2015
PubMed
Summary
This summary is machine-generated.

Treatment-resistant hypertension (TRH) affects 10-20% of patients, posing a significant clinical challenge. Effective management, including options like renal denervation for select cases, is crucial to reduce cardiovascular events.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

886

Related Experiment Videos

Last Updated: Apr 11, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

886

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Medicine

Background:

  • Treatment-resistant hypertension (TRH) affects 10-20% of hypertensive patients.
  • TRH significantly increases the risk of major cardiovascular and cerebrovascular events annually (up to 5%).
  • Managing TRH presents a substantial clinical challenge requiring effective strategies.

Purpose of the Study:

  • To highlight the clinical challenges in managing treatment-resistant hypertension.
  • To emphasize the importance of treatment options that maximize patient compliance.
  • To discuss the potential role of renal denervation in specific TRH patient subsets.

Main Methods:

  • Review of clinical data and treatment guidelines for resistant hypertension.
  • Analysis of patient compliance factors in antihypertensive therapy.
  • Evaluation of evidence supporting combination therapies and interventional procedures like renal denervation.

Main Results:

  • TRH is a prevalent condition associated with high annual event rates.
  • Maximizing treatment compliance is a key recommendation for effective TRH management.
  • Combination therapies with clinical study support are advised.
  • Renal denervation is a viable option for carefully selected TRH patients.

Conclusions:

  • Effective management of TRH is critical due to its high prevalence and associated event risks.
  • Prioritizing treatment compliance and utilizing evidence-based combination therapies are essential.
  • Renal denervation offers a therapeutic option for a specific subset of patients with truly resistant hypertension.